Selective Serotonin Reuptake Inhibitors for Late-Life DepressionA Comparative Review

被引：0
作者：
LalithKumar K. Solai
Benoit H. Mulsant
Bruce G. Pollock
机构：
[1] University of Pittsburgh School of Medicine,VA Pittsburgh Healthcare System
[2] University of Pittsburgh School of Medicine and Geriatric Research,Psychopharmacology and Pharmaceutical Sciences
[3] Education,Western Psychiatric Institute and Clinic
[4] and Clinical Center,undefined
[5] University of Pittsburgh School of Medicine and Geriatric Psychopharmacology Program,undefined
[6] University of Pittsburgh Medical Center,undefined
[7] UPMC Beaver Valley Mental Health Services,undefined
来源：
Drugs & Aging | 2001年 / 18卷
关键词：
Fluoxetine; Paroxetine; Sertraline; Fluvoxamine; Cisapride;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Late-life depression is a serious health problem that is challenging to manage but generally responds well to pharmacotherapy. Selective serotonin (5-hydroxy-tryptamine; 5-HT) reuptake inhibitors (SSRIs), the most commonly prescribed antidepressants, are usually used as first-line agents for elderly patients with depression. Like most drugs, SSRIs have not been widely tested in clinical trials that approximate ‘real-life’ geriatric situations. However, studies completed to date provide valuable information about the efficacy, safety and tolerability of this class of antidepressants among older patients with depression, including those with depression secondary to stroke or dementia and those with other comorbid physical disorders.
引用
收藏
页码：355 / 368
页数：13
相关论文
共 194 条
[21]  
Tollefson GD(1991)The use and toler-ability of fluoxetine in geropsychiatric inpatients Br J Clin Pract 45 255-8
[22]  
Bosomworth JC(1991)Fluvoxamine in the treatment of the older depressed patient: double-blind, placebo-controlled data Acta Psychiatr Scand 83 476-9
[23]  
Heiligenstein JH(1992)A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients J Clin Psychiatry 53 57-60
[24]  
Altamura AC(1989)Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people Acta Psychiatr Scand Suppl 350 132-4
[25]  
De Novellis F(1995)Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression Psychopharmacology (Berl) 119 277-81
[26]  
Guercetti G(1998)A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients Int J Geriatr Psychiatry 13 100-8
[27]  
Feighner JP(1999)Multicenter double-blind study of paroxetine and amitriptyline in elderly depressed inpatients J Clin Psychiatry 60 16-20
[28]  
Cohn JB(2000)A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia Am J Psychiatry 157 729-36
[29]  
Schone W(2000)A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome J Clin Psychiatry 61 559-68
[30]  
Ludwig M(1990)Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life J Clin Psychiatry 51 28-33
12345678910